GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well...

Full description

Saved in:
Bibliographic Details
Main Authors DA SILVA, Ana Paula Galvao, GHADERI, Darius, DESANDER, Julie, EAVARONE, David A, PRENDERGAST, Jillian M, ZHANG, Mai, MEETZE, Kristan, BEHRENS, Jeffrey
Format Patent
LanguageEnglish
French
German
Published 02.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
Bibliography:Application Number: EP20220201604